In 2005 Bauch (Phils.) Laboratories Corporation was established under the ANFLO Group of Companies with a vision of becoming a major player in the Philippine pharmaceutical industry. BAUCH, which is the third arm of ANFLO Group, is mainly engaged in manufacturing ethical, consumer and nutraceutical products. Among this group of companies are the long-standing enterprises such as ANFLO Interchemical Supply Corp., a leading pharmaceutical and veterinary raw material importer and trader for 26 years; and LOAR Pharmaceutical Co., Inc., mainly engaged in the trading, wholesaling and distributorship of pharmaceutical finished goods for 18 years.
Combining decades of experience in distributing active ingredients and excipients to the Philippine pharmaceutical industries with modern methods and high technology manufacturing system, Bauch Lab embarked in building a new pharmaceutical manufacturing laboratory in Silang, Cavite, compliant to Philippine FDA cGMP/PICS standards.
Our 11,537 sqm. manufacturing plant with 1,900 sqm. of building floor area is fully equipped with the state of the art production machineries and laboratory instruments capable of producing 80 Million (6.5 million per month) capsules and tablets annually in a single shift.
The company was granted its license to operate in June 2011 and had its grand opening in February 2012. In January 2013, the first two drug CPRs (Certificate of Product Registration) were received for Calcium Ascorbate (Calcibate-C) and Sodium Ascorbate (Florvit-C). This was followed by the release of the CPRs (Certificate of Product Registration) for our nutraceuticals: Borage Oil (Blooming-G) and Flaxseed Oil (Flaxiflor). At least 19 more products are in the pipeline for FDA registration for 2013.
On September 2013, the Philippine FDA has certified BAUCH for its Good Manufacturing Practices, with Certificate No. DM-2013-85, subsequent to the renewal of the BAUCH LTO as Drug Manufacturer with LTO No. CDRR-RIV-DM-77.
In 2014, BAUCH has conducted its successive product launches for its own products. Subsequent to this in 2015, BAUCH has opened its doors to contract manufacturing business wherein it partners with clients in the pharmaceutical industry.
With such development, Bauch is well on its way towards creating a corporate culture of excellence and innovation.